Last edition
News about "Takeda Pharmaceuticals USA"
Alembic Wins US FDA Approval for Prucalopride Tablets
Alembic Pharmaceuticals has received US Food and Drug Administration (FDA) approval for generic Prucalopride Tablets, equivalent to Takeda's Motegrity, for Chronic Idiopathic Constipation (CIC).
Takeda Pharmaceuticals USA | 29/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members